Sterling Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Sell |
18,165
-132
| -0.7% | -$9.22K | 0.02% | 545 |
|
|
2025
Q1 | $1.34M | Buy |
18,297
+1,833
| +11% | +$135K | 0.02% | 500 |
|
|
2024
Q4 | $1.08M | Buy |
16,464
+5,835
| +55% | +$382K | 0.01% | 614 |
|
|
2024
Q3 | $828K | Buy |
+10,629
| New | +$828K | 0.01% | 650 |
|
|
2019
Q3 | $249K | Sell |
5,590
-1,734
| -24% | -$77.2K | ﹤0.01% | 809 |
|
|
2019
Q2 | $302K | Buy |
7,324
+986
| +16% | +$40.7K | ﹤0.01% | 798 |
|
|
2019
Q1 | $256K | Buy |
6,338
+528
| +9% | +$21.3K | ﹤0.01% | 794 |
|
|
2018
Q4 | $221K | Sell |
5,810
-2,226
| -28% | -$84.7K | ﹤0.01% | 813 |
|
|
2018
Q3 | $318K | Sell |
8,036
-127
| -2% | -$5.03K | ﹤0.01% | 816 |
|
|
2018
Q2 | $287K | Buy |
8,163
+494
| +6% | +$17.4K | ﹤0.01% | 799 |
|
|
2018
Q1 | $268K | Buy |
7,669
+249
| +3% | +$8.7K | ﹤0.01% | 810 |
|
|
2017
Q4 | $257K | Buy |
7,420
+105
| +1% | +$3.64K | ﹤0.01% | 826 |
|
|
2017
Q3 | $248K | Buy |
+7,315
| New | +$248K | ﹤0.01% | 852 |
|
|
2017
Q2 | – | Sell |
-9,853
| Closed | -$307K | – | 934 |
|
|
2017
Q1 | $307K | Buy |
9,853
+561
| +6% | +$17.5K | ﹤0.01% | 847 |
|
|
2016
Q4 | $254K | Buy |
+9,292
| New | +$254K | ﹤0.01% | 868 |
|
|
2016
Q3 | – | Sell |
-8,699
| Closed | -$263K | – | 906 |
|
|
2016
Q2 | $263K | Sell |
8,699
-6,235
| -42% | -$189K | ﹤0.01% | 842 |
|
|
2016
Q1 | $421K | Buy |
+14,934
| New | +$421K | ﹤0.01% | 774 |
|